Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer

dc.contributor.authorMroueh, Fatima Mohsen
dc.contributor.authorNoureldein, Mohamed H.
dc.contributor.authorZeidan, Youssef H.
dc.contributor.authorBoutary, Suzan S.
dc.contributor.authorIrani, Sara Abou Merhi
dc.contributor.authorEid, Stéphanie A.
dc.contributor.authorHaddad, Mary
dc.contributor.authorBarakat, Rasha
dc.contributor.authorHarb, Frédéric F.
dc.contributor.authorCostantine, Joseph
dc.contributor.authorKanj, Rouwaida N.
dc.contributor.authorSauleau, Erik A.
dc.contributor.authorOuhtit, Allal
dc.contributor.authorAzar, Sami T.
dc.contributor.authorEid, Ali H.
dc.contributor.authorEid, Assaad A.
dc.contributor.departmentDepartment of Electrical and Computer Engineering
dc.contributor.departmentInternal Medicine
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.departmentDiabetes
dc.contributor.facultyMaroun Semaan Faculty of Engineering and Architecture (MSFEA)
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:29:53Z
dc.date.available2025-01-24T11:29:53Z
dc.date.issued2019
dc.description.abstractCancer was recently annexed to diabetic complications. Furthermore, recent studies suggest that cancer can increase the risk of diabetes. Consequently, diabetes and cancer share many risk factors, but the cellular and molecular pathways correlating diabetes and colon and rectal cancer (CRC) remain far from understood. In this study, we assess the effect of hyperglycemia on cancer cell aggressiveness in human colon epithelial adenocarcinoma cells in vitro and in an experimental animal model of CRC. Our results show that Nox (NADPH oxidase enzyme) 4-induced reactive oxygen species (ROS) production is deregulated in both diabetes and CRC. This is paralleled by inactivation of the AMPK and activation of the mammalian target of rapamycin (mTOR) C1 signaling pathways, resulting in 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) accumulation, induction of DNA damage, and exacerbation of cancer cell aggressiveness, thus contributing to the genomic instability and predisposition to increased tumorigenesis in the diabetic milieu. Pharmacologic activation of AMPK, inhibition of mTORC1, or blockade of Nox4 reduce ROS production, restore the homeostatic signaling of 8-oxoguanine DNA glycosylase/8-oxodG, and lessen the progression of CRC malignancy in a diabetic milieu. Taken together, our results identify the AMPK/mTORC1/Nox4 signaling axis as a molecular switch correlating diabetes and CRC. Modulating this pathway may be a strategic target of therapeutic potential aimed at reversing or slowing the progression of CRC in patients with or without diabetes.—Mroueh, F. M., Noureldein, M., Zeidan, Y. H., Boutary, S., Irani, S. A. M., Eid, S., Haddad, M., Barakat, R., Harb, F., Costantine, J., Kanj, R., Sauleau, E.-A., Ouhtit, A., Azar, S. T., Eid, A. H., Eid, A. A. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer. FASEB J. 33, 14051-14066 (2019). www.fasebj.org. © FASEB.
dc.identifier.doihttps://doi.org/10.1096/fj.201900396RR
dc.identifier.eid2-s2.0-85076066200
dc.identifier.pmid31661292
dc.identifier.urihttp://hdl.handle.net/10938/27331
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofFASEB Journal
dc.sourceScopus
dc.subjectColorectal cancer
dc.subjectDna damage
dc.subjectMtorc1
dc.subjectNadph oxidases
dc.subjectAmp-activated protein kinases
dc.subjectAnimals
dc.subjectAntibiotics, antineoplastic
dc.subjectBlood glucose
dc.subjectCaco-2 cells
dc.subjectDiabetes mellitus, experimental
dc.subjectGene expression regulation, neoplastic
dc.subjectHt29 cells
dc.subjectHumans
dc.subjectHypoglycemic agents
dc.subjectMale
dc.subjectMetformin
dc.subjectMice
dc.subjectMice, inbred c57bl
dc.subjectMice, transgenic
dc.subjectNadph oxidase 4
dc.subjectSirolimus
dc.subjectTor serine-threonine kinases
dc.subjectUp-regulation
dc.subjectAntidiabetic agent
dc.subjectAntineoplastic antibiotic
dc.subjectHydroxymethylglutaryl coenzyme a reductase kinase
dc.subjectMtor protein, human
dc.subjectMtor protein, mouse
dc.subjectNox4 protein, human
dc.subjectNox4 protein, mouse
dc.subjectReduced nicotinamide adenine dinucleotide phosphate oxidase 4
dc.subjectTarget of rapamycin kinase
dc.subjectAnimal
dc.subjectC57bl mouse
dc.subjectCaco-2 cell line
dc.subjectDrug effect
dc.subjectExperimental diabetes mellitus
dc.subjectGene expression regulation
dc.subjectGenetics
dc.subjectGlucose blood level
dc.subjectHt-29 cell line
dc.subjectHuman
dc.subjectMetabolism
dc.subjectMouse
dc.subjectTransgenic mouse
dc.subjectUpregulation
dc.titleUnmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2019-7155.pdf
Size:
2.36 MB
Format:
Adobe Portable Document Format